Investing in the Backbone of
Life Science
We invest in European Life Science Real Estate along the value chain of the Life Science sector. Ask for our current investment criteria.
R&D/ Labs
We invest in highly specialized laboratory environments tailored to the diverse needs of life science users.
These include wet labs, dry labs, cleanroom laboratories, and flexible R&D spaces.
Whether it’s collaborative innovation zones or regulated environments like GLP-compliant cleanrooms, our lab infrastructure is designed to enable cutting-edge research and support rapid development cycles.
Manufacturing
Our production assets are built for excellence in pharmaceutical and biotech manufacturing.
These facilities are engineered with strict environmental controls, GMP/GLP compliance, and modular adaptability – supporting everything from pilot production to full-scale manufacturing in medtech and biopharma.
Logistics
We invest in logistics spaces that meet the high standards of life science operations — including temperature-controlled environments and hygienic surfaces, supporting the secure, efficient flow of sensitive materials.
These assets play a critical role in maintaining supply chain integrity from production through to patient delivery.
The way we invest
European Investment Approach
Life Science Real Estate is inherently international, with Europe offering globally relevant clusters supported by leading research institutions, established industry ecosystems and strong public infrastructure.
At the same time, real estate remains fundamentally local. Market access, occupier networks, planning frameworks, transaction practices and cluster dynamics differ significantly between locations.
HELIX alpha therefore combines a focused pan-European approach with local market expertise. Our European representatives contribute first-hand market knowledge, established networks and direct access to local Life Science ecosystems – supporting our activities across both Investment Management and Advisory.
Our core markets are shown in blue on the map, with the extended investment universe
shown in green.
Our European Network
European perspective. Local market insight.
HELIX alpha operates as one integrated European platform. Our management, Advisory Board, Director Advisory and
European representatives bring together institutional investment expertise, Life Science knowledge and
first-hand market access across our activities.
Hamburg
Headquarters
Spain
Manuel Tabuyo ·
Ignacio Salvador
Madrid
France
Dominique Dudan FRICS
Paris
Nordics
Mikael Wadsten
Stockholm
Our investment products
Taylormade investment solutions
At Helix alpha, we tailor our investment structures to the specific needs of our predominantly institutional and regulated investor base. With deep experience across a broad range of investment vehicles, we offer flexible and compliant solutions aligned with individual requirements and regulatory frameworks.
Depending on investor preferences and jurisdictional considerations, we implement the solution that best fits our clients' needs, including:
-
Regulated fund products
-
Separate accounts / mandates
-
Club deals
-
Joint ventures
In terms of investment law, our investments can generally be allocated to the property or infrastructure quota - which is a major advantage.
For regulated vehicles, we collaborate with leading fund service providers and licensed AIFMs in both Germany and Luxembourg.
While the fund service provider ensures comprehensive support in areas such as accounting, tax & legal, risk management, treasury, and valuation, Helix Alpha retains full responsibility for all performance-related aspects, including sourcing, structuring, asset management, and value creation.
Our solutions combine regulatory reliability with operational excellence - designed to meet the high standards of professional investors.